374 related articles for article (PubMed ID: 15661423)
1. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo.
Chester JD; Kennedy W; Hall GD; Selby PJ; Knowles MA
Gene Ther; 2003 Jan; 10(2):172-9. PubMed ID: 12571646
[TBL] [Abstract][Full Text] [Related]
3. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
4. A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium.
Lin LF; Zhu G; Yoo JJ; Soker S; Sukhatme VP; Atala A
J Urol; 2002 Aug; 168(2):813-8. PubMed ID: 12131373
[TBL] [Abstract][Full Text] [Related]
5. Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
Pagliaro LC; Keyhani A; Williams D; Woods D; Liu B; Perrotte P; Slaton JW; Merritt JA; Grossman HB; Dinney CP
J Clin Oncol; 2003 Jun; 21(12):2247-53. PubMed ID: 12805322
[TBL] [Abstract][Full Text] [Related]
6. Myocardial injury-induced fibroblast proliferation facilitates retroviral-mediated gene transfer to the rat heart in vivo.
Byun J; Huh JE; Park SJ; Jang JE; Suh YL; Lee JS; Gwon HC; Lee WR; Cosset FL; Kim DK
J Gene Med; 2000; 2(1):2-10. PubMed ID: 10765500
[TBL] [Abstract][Full Text] [Related]
7. Postoperative immuno-gene therapy of murine bladder tumor by in vivo administration of retroviruses expressing mouse interferon-gamma.
Shiau AL; Lin CY; Tzai TS; Wu CL
Cancer Gene Ther; 2001 Jan; 8(1):73-81. PubMed ID: 11219496
[TBL] [Abstract][Full Text] [Related]
8. Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model.
Siemens DR; Crist S; Austin JC; Tartaglia J; Ratliff T
J Urol; 2003 Sep; 170(3):979-84. PubMed ID: 12913754
[TBL] [Abstract][Full Text] [Related]
9. Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo.
Bass C; Cabrera G; Elgavish A; Robert B; Siegal GP; Anderson SC; Maneval DC; Curiel DT
Cancer Gene Ther; 1995 Jun; 2(2):97-104. PubMed ID: 7621262
[TBL] [Abstract][Full Text] [Related]
10. [Retroviral-mediated transfer of a hygromycin phosphotransferase-thymidine kinase fusion gene into human bladder carcinoma cell].
Ye C; Chen S; Pei X; Li L; Feng K
Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):453-5, 33. PubMed ID: 11829886
[TBL] [Abstract][Full Text] [Related]
11. Intravesical liposome-mediated interleukin-2 gene therapy in orthotopic murine bladder cancer model.
Horiguchi Y; Larchian WA; Kaplinsky R; Fair WR; Heston WD
Gene Ther; 2000 May; 7(10):844-51. PubMed ID: 10845722
[TBL] [Abstract][Full Text] [Related]
12. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
Wu Q; Mahendran R; Esuvaranathan K
Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gene transfer efficiency by viral vectors to murine bladder epithelium.
Siemens DR; Austin JC; See WA; Tartaglia J; Ratliff TL
J Urol; 2001 Feb; 165(2):667-71. PubMed ID: 11176455
[TBL] [Abstract][Full Text] [Related]
14. Transplantation of retrovirus-transduced canine keratinocytes expressing the beta-galactosidase gene.
Stockschläder MA; Schuening FG; Graham TC; Storb R
Gene Ther; 1994 Sep; 1(5):317-22. PubMed ID: 7584097
[TBL] [Abstract][Full Text] [Related]
15. [Study of the synergy of microwave hyperthermia/intravesical chemotherapy in the prevention of recurrences of superficial tumors of the bladder].
Mauroy B; Bonnal JL; Prevost B; Chive M; Lhotellier V; Sozanski JP; Vanseymortier L; Stefaniak X
Prog Urol; 1999 Feb; 9(1):69-80. PubMed ID: 10212955
[TBL] [Abstract][Full Text] [Related]
16. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
Watanabe T; Shinohara N; Sazawa A; Harabayashi T; Ogiso Y; Koyanagi T; Takiguchi M; Hashimoto A; Kuzumaki N; Yamashita M; Tanaka M; Grossman HB; Benedict WF
Cancer Gene Ther; 2000 Dec; 7(12):1575-80. PubMed ID: 11228536
[TBL] [Abstract][Full Text] [Related]
17. Direct synovial gene transfer with retroviral vectors in rat adjuvant arthritis.
Nguyen KH; Boyle DL; McCormack JE; Chada S; Jolly DJ; Firestein GS
J Rheumatol; 1998 Jun; 25(6):1118-25. PubMed ID: 9632074
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a semi-replicative gene delivery system allowing propagation of complementary defective retroviral vectors.
Trajcevski S; Solly SK; Frisén C; Trenado A; Cosset FL; Klatzmann D
J Gene Med; 2005 Mar; 7(3):276-87. PubMed ID: 15515136
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
[TBL] [Abstract][Full Text] [Related]
20. Muscle derived cell mediated ex vivo gene transfer to the lower urinary tract: comparison of viral vectors.
Pruchnic R; Yokoyama T; Lee JY; Huard J; Chancellor MB
Urol Res; 2002 Oct; 30(5):310-6. PubMed ID: 12389119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
